Submitted by Anonymous (not verified) on 13 November 2023 - 10:40
Opinion/decision on a Paediatric investigation plan (PIP): Namilumab, decision type: , therapeutic area: , PIP number: P/0471/2022
Source:
Opinion/decision on a Paediatric investigation plan (PIP): Namilumab, decision type: , therapeutic area: , PIP number: P/0471/2022